⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25991026 | 0.69 | — | — | |
| Ethane SCHEMBL7025474 | 0.67 | — | — | |
| SCHEMBL25987604 | 0.67 | — | — | |
| SCHEMBL50770 | 0.66 | — | — | |
| SCHEMBL25991095 | 0.65 | — | — | |
| SCHEMBL24003797 | 0.63 | — | — | |
| Methane SCHEMBL27926612 | 0.63 | — | — | |
| Fluoride SCHEMBL27345232 | 0.63 | — | — | |
| Hydrochloric Acid SCHEMBL27453844 | 0.63 | — | — | |
| SCHEMBL25987635 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021048809-A9 | NOVEL SUBSTITUTED SULFOXIMINE DERIVATIVES | CADILA HEALTHCARE LIMITED (IN) | 2023-01-19 | — | — | WO | disclosed |
| EP-4027986-A1 | NOVEL SUBSTITUTED SULFOXIMINE DERIVATIVES | Cadila Healthcare Limited (IN) | 2022-07-20 | — | — | EP | disclosed |